Zodasiran

Drug identity checked against registry records

Also recorded as ARO-ANG3

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of Zodasiran in Adolescent Participants With Homozygous Familial HypercholesterolemiaNCT07473843Arrowhead PharmaceuticalsPhase 3Recruiting2028-07Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.